Contraceptives Market .pdf

Contraceptives MarketOut of all these segments, contraceptive devices held the biggest market share, at about 60%, in2013. This segment owes its huge success to the popularity of devices such as copper IUDs,male condoms, and inexpensive sub-dermal contraceptive implants such as sino-implants. By2020, the contraceptive devices segment is expected to grow at a CAGR of more than 3.5%. Thecontraceptives market is expected to witness a steady growth rate; the introduction of femalecondoms such as Bayer’s Skyla in the U.S. market and Jaydess in the European market willencourage this segment to expand in newer directions. Additionally, reduction in the price ofJadelle, a subdermal implant by Bayer HealthCare will also support the contraceptives market inthe coming few years.Browse the full Press Release:http://www.transparencymarketresearch.com/pressrelease/contraceptives-market.htmIn terms of geography, North America held a dominant market share of more than 40% in 2013.However, Asia Pacific is expected to dominate this region with a CAGR of 4.5% in the forecastperiod. Countries such as India and China will contribute significantly to this phenomenon withtheir huge population base, rising disposable incomes, and growing awareness about the usageof contraceptives.Some of the major market players profiled in this report are Bayer AG, Actavis Inc.,CooperSurgical Inc., Church & Dwight Co. Inc., Mayer Laboratories Inc., Merck & Co. Inc., ReckittBenckiser plc, Pfizer Inc., The Female Health Company, and Teva Pharmaceutical Industries Ltd.TABLE OF CONTENTChapter 1 Introduction1.1 Report Description1.2 Market SegmentationTransparency Market Research3